Influence of preoperative cyclosporine administration on HLA expression: a comparison of two treatment patterns.
Wojnicz
R
R
Silesian Centre of Heart Disease, Zabrze, Poland.
Zakliczyński
M
M
Szkodziński
J
J
Nowak
J
J
Rozentryt
P
P
Foremny
J
J
Poloński
L
L
Zembala
M
M
D000328:Adult; D001379:Azathioprine / Q000494:pharmacology; D016572:Cyclosporine / Q000494:pharmacology*; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000494:pharmacology; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006684:HLA-DR Antigens / Q000378:metabolism; D016027:Heart Transplantation / Q000276:immunology*; D015395:Histocompatibility Antigens Class I / Q000378:metabolism; D000949:Histocompatibility Antigens Class II / Q000378:metabolism*; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000494:pharmacology; D013997:Time Factors
D005938:Glucocorticoids; D006684:HLA-DR Antigens; D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine